Romania – Medical equipments – Dotarea Spitalului de Ortopedie și Traumatologie Azuga cu aparatură medicală și accesorii 2026

Romania – Various medicinal products – Furnizare medicamente diverse si medicamente specifice sectiei oncologie

Romania – Laboratory reagents – ACORD CADRU DE FURNIZARE REACTIVI DE LABORATOR-16 LOTURI

Expected Outcome: This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: Fully programmable industry-ready quantum simulators based on 10.000 neutral atoms in a scalable architecture, accessible via cloud platforms, and with the possibility of integrating them into high-performance computing environments. Fully programmable platform for neutral-atom quantum computing capable of both analogue quantum operations and gate-based computing with 1.000 physical qubits and a clear path to further scalability to 10.000 physical qubits. Coherence time of the order of hundreds of interaction times and infidelity of operations below 1%. Demonstration of quantum simulation and/or computing operating beyond classical computability, validated through benchmarking with classical methods. New real-world applications across science and industry (at least two) (e.g: in the energy and health sectors) The software stack for these applications, including enhanced software for verification, algorithm implementation, and user programming interfaces. Demonstration of the full quantum stack – including quantum control, electronic…

Spain – Medical consumables – Suministro de equipos de cobertura quirúrgica desechable, material auxiliar y elementos fungibles asociados para la Osi Bilbao Basurto, y puesta a disposición de un modelo de gestión logística automat

Sweden – CT scanners – Datortomografer

Denmark – Pharmaceutical products – Amgros 2027 1.487.a

The Great British Energy (GBE) Supply Chain Fund: Offshore Wind and Networks will award up to £300 million in capital grant funding to build UK manufacturing capacity for key constrained components in offshore wind and enabling electricity networks sectors. Funding must be used to construct new or extend existing manufacturing facilities in the UK. The application window will close 10 December 2026 (or earlier if the Fund's budget is fully allocated).

Silicon Carbide Cladding Lead Test Rod Development-Phase 1Research, development, and fabrication of Silicon Carbide cladding specimens for research reactor insertion, irradiation, and post-irradiation examinations by 2030. The objective of this program is to advance the scientific and technological maturity of silicon carbide cladding for nuclear fuel rods for future use in commercial light water reactors.

Expected Outcome: The successful proposal is expected to further contribute to the expected outcomes specified in topic HORIZON-CL6-2024-GOVERNANCE-02-01: European Partnership of Agriculture of Data, for continuation of the activities in line with already agreed outcomes. Scope: The objective of this action is to continue to provide support to the European partnership of Agriculture of Data identified in the Horizon Europe Strategic Plan 2021-2024 and first implemented under the topic HORIZON-CL6-2024-GOVERNANCE-02-01: European Partnership of Agriculture of Data, and in particular to fund additional activities (which may also be undertaken by additional partners) in view of its intended scope and duration, and in accordance with Article 24(2) of the Horizon Europe Regulation. The consortium which applied to and received funding under HORIZON-CL6-2024-GOVERNANCE-02-01: European Partnership of Agriculture of Data is uniquely placed to submit a proposal to continue the envisioned partnership. Not only did this consortium submit the proposal leading to the identification of the partnership in the Horizon Europe strategic planning 2021-2024, it has also been implementing the…

Expected Outcome: This action will consolidate Europe’s position in superconducting quantum computing through: Establishment of a full-stack superconducting quantum computer aiming at 1.000 physical qubits and QPU architecture based on chiplet technology. The system should feature a scalable and user-adjustable architecture, T1 coherence time above 100 us, gate fidelities (both one- and two-qubit gates, and read-out) of at least 99.9%, read-out speed below 300 ns, two-qubit gate speed below 20 ns. Demonstration of quantum advantage on selected industrial use cases, validated through benchmarking with best-in-class classical methods. Deployment of a cloud-accessible quantum system integrated with high-performance computing environments. Maturation of fault-tolerant quantum computing protocols, including effective quantum error correction and noise mitigation schemes. Delivery of a comprehensive, standardised software stack supporting system bring-up, calibration, control, benchmarking, and user access. Strengthened supply chains and industrial capacity in Europe for superconducting quantum technologies. Scope: The proposal should contribute to the scale-up and practical deployment…